DEKAVIL (F8-IL10), A NOVEL THERAPEUTIC APPROACH FOR RHEUMATOID ARTHRITIS: ONGOING PHASE IB CLINICAL TRIAL RESULTS

Category Primary study
JournalANNALS OF THE RHEUMATIC DISEASES
Year 2015
This article has no abstract
Epistemonikos ID: 250d6ef2e086ee2cde9e760b79a52da9ceccf633
First added on: Mar 23, 2022